Even Though Evolent Health (NYSE:EVH) Has Lost US$230m Market Cap in Last 7 Days, Shareholders Are Still up 92% Over 5 Years

It might be of some concern to shareholders to see the Evolent Health, Inc. (NYSE:EVH) share price down 16% in the last month. On the other hand the returns over the last half decade have not been

Simply Wall StApr 29 21:39

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Evolent Health (EVH) and BioMarin Pharmaceutical (BMRN)

TipRanksApr 25 19:02

In-Depth Examination Of 6 Analyst Recommendations For Evolent Health

Evolent Health (NYSE:EVH) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a snapshot of their recen

BenzingaApr 23 04:02

Evolent Health Initiated at Buy by Citigroup

Evolent Health Initiated at Buy by Citigroup

Dow JonesApr 22 21:07

Evolent Health (EVH.US) was first covered by Citi, giving it a buy rating, with a target price of $40.00.

Evolent Health (EVH.US) was first covered by Citi, giving it a buy rating, with a target price of $40.00.

Zhitong FinanceApr 22 21:01

Citigroup Initiates Coverage On Evolent Health With Buy Rating, Announces Price Target of $40

Citigroup analyst Daniel Grosslight initiates coverage on Evolent Health with a Buy rating and announces Price Target of $40.

Analyst UpgradesApr 22 20:57